Securian Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$723K Hold
3,945
0.03% 451
2025
Q4
$694K Sell
3,945
-3,005
-43% -$491K 0.03% 467
2025
Q3
$974K Sell
6,950
-646
-9% -$87.3K 0.03% 446
2025
Q2
$954K Sell
7,596
-100
-1% -$12.5K 0.03% 444
2025
Q1
$1.05M Hold
7,696
0.03% 400
2024
Q4
$1.18M Sell
7,696
-300
-4% -$50.6K 0.03% 375
2024
Q3
$1.55M Sell
7,996
-300
-4% -$62.8K 0.04% 316
2024
Q2
$1.92M Sell
8,296
-200
-2% -$43.5K 0.06% 272
2024
Q1
$1.83M Sell
8,496
-683
-7% -$160K 0.05% 289
2023
Q4
$2.38M Sell
9,179
-1,201
-12% -$295K 0.07% 236
2023
Q3
$2.67M Sell
10,380
-1,713
-14% -$458K 0.08% 217
2023
Q2
$3.44M Hold
12,093
0.09% 202
2023
Q1
$3.36M Buy
12,093
+100
+0.8% +$27.7K 0.09% 206
2022
Q4
$3.32M Buy
11,993
+182
+2% +$51.4K 0.09% 202
2022
Q3
$3.15M Sell
11,811
-100
-0.8% -$21.2K 0.09% 195
2022
Q2
$2.43M Hold
11,911
0.06% 302
2022
Q1
$2.51M Sell
11,911
-200
-2% -$43.5K 0.05% 346
2021
Q4
$2.91M Sell
12,111
-623
-5% -$160K 0.05% 322
2021
Q3
$3.6M Sell
12,734
-252
-2% -$82.6K 0.07% 253
2021
Q2
$4.5M Sell
12,986
-274
-2% -$83K 0.09% 214
2021
Q1
$3.71M Sell
13,260
-504
-4% -$136K 0.08% 235
2020
Q4
$3.37M Sell
13,764
-676
-5% -$174K 0.08% 250
2020
Q3
$4.1M Sell
14,440
-566
-4% -$158K 0.1% 209
2020
Q2
$4.01M Sell
15,006
-2,736
-15% -$822K 0.1% 207
2020
Q1
$5.61M Sell
17,742
-266
-1% -$80.7K 0.16% 148
2019
Q4
$5.34M Sell
18,008
-1,123
-6% -$312K 0.12% 189
2019
Q3
$4.45M Sell
19,131
-1,232
-6% -$287K 0.1% 210
2019
Q2
$4.76M Sell
20,363
-100
-0.5% -$23.1K 0.11% 189
2019
Q1
$4.84M Sell
20,463
-248
-1% -$78.1K 0.12% 181
2018
Q4
$6.23M Buy
20,711
+17
+0.1% +$5.42K 0.17% 136
2018
Q3
$7.31M Sell
20,694
-1,006
-5% -$346K 0.17% 127
2018
Q2
$6.3M Buy
21,700
+100
+0.5% +$28.1K 0.16% 139
2018
Q1
$5.92M Sell
21,600
-100
-0.5% -$31K 0.15% 150
2017
Q4
$6.91M Buy
21,700
+120
+0.6% +$38.5K 0.17% 136
2017
Q3
$6.76M Buy
21,580
+18
+0.1% +$5.33K 0.18% 140
2017
Q2
$5.85M Sell
21,562
-300
-1% -$79.3K 0.15% 148
2017
Q1
$5.98M Sell
21,862
-48
-0.2% -$13.6K 0.16% 142
2016
Q4
$6.21M Sell
21,910
-127
-0.6% -$37.6K 0.17% 143
2016
Q3
$6.9M Buy
22,037
+215
+1% +$63.7K 0.19% 125
2016
Q2
$5.28M Buy
21,822
+343
+2% +$90.4K 0.15% 149
2016
Q1
$5.59M Sell
21,479
-246
-1% -$65K 0.16% 138
2015
Q4
$6.66M Sell
21,725
-481
-2% -$138K 0.2% 121
2015
Q3
$6.48M Sell
22,206
-125
-0.6% -$41.3K 0.21% 112
2015
Q2
$9.02M Buy
22,331
+314
+1% +$126K 0.28% 88
2015
Q1
$9.3M Buy
22,017
+545
+3% +$215K 0.27% 87
2014
Q4
$7.29M Buy
21,472
+606
+3% +$196K 0.23% 105
2014
Q3
$6.9M Sell
20,866
-404
-2% -$133K 0.23% 99
2014
Q2
$6.71M Buy
21,270
+124
+0.6% +$37.3K 0.23% 103
2014
Q1
$6.47M Buy
21,146
+153
+0.7% +$48.6K 0.23% 102
2013
Q4
$5.87M Sell
20,993
-265
-1% -$68.5K 0.22% 114
2013
Q3
$5.12M Buy
21,258
+400
+2% +$89.5K 0.21% 119
2013
Q2
$4.49M Buy
+20,858
New +$4.46M 0.18% 127

Other funds holding BIIB

Securian Asset Management's BIIB Position: Q1 2026 in Review

Securian Asset Management held its Biogen (BIIB) position steady in Q1 2026 at 3,945 shares worth $723K. The position accounts for 0.03% of the portfolio, ranked #451.

Securian Asset Management first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.3M in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Securian Asset Management held 3,945 shares of Biogen worth $723K as of Q1 2026.
  • Securian Asset Management left its Biogen share count unchanged in Q1 2026.
  • Biogen made up 0.03% of Securian Asset Management's portfolio in Q1 2026, its #451 holding.
  • Securian Asset Management first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
  • Securian Asset Management's Biogen position peaked at $9.3M in Q1 2015.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Securian Asset Management's 13F filing for Q1 2026, filed 1 May 2026.